Akeso Inc.

08/05/2021 | Press release | Distributed by Public on 08/04/2021 16:14

VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR PENPULIMAB MONOCLONAL ANTIBODY (PD-1) FOR THIRD-LINE TREATMENT OF METASTATIC NASOPHARYNGEAL CARCINOMA ACCEPTED BY NMPA